Skip to main content

A-769662

ENZ-CHM360

  • ENZ-CHM360-0025   —   25 mg
    $330.00
  • GMP format available

A-769662 is a potent activator of AMP-activated protein kinase (AMPK), with an EC50 of 0.8 µM in vitro. It specifically targets AMPK heterotrimers containing the β1 subunit.

Key features and applications include:

  • High Selectivity: Selectively activates AMPK β1 subunit-containing heterotrimers.
  • Potency: Demonstrates strong activation with an EC50 of 0.8 µM.
  • Stimulate Fatty Acid Oxidation: Promotes fatty acid oxidation in various cell types.
  • Inhibit Adipocyte Differentiation: Reduces differentiation of preadipocytes into adipocytes.
  • Enhance Glucose Uptake: Increases glucose uptake in skeletal muscle cells.
  • Promote Endothelial Cell Survival: Supports endothelial cell survival during metabolic stress.
    Relevant disease states include:
  • Type 2 Diabetes: Improves glucose homeostasis and reduces plasma glucose levels.
  • Obesity: Inhibits adipogenesis, making it useful in obesity research.
  • Metabolic Syndrome: Addresses key components of metabolic syndrome by activating AMPK.
  • Cardiovascular Diseases: Enhances endothelial cell survival, which is beneficial in cardiovascular research.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only